BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32312148)

  • 1. Expression of the nucleoside transporters hENT1 (SLC29) and hCNT1 (SLC28) in pediatric acute myeloid leukemia.
    Jaramillo AC; Hubeek I; Broekhuizen R; Pastor-Anglada M; Kaspers GJL; Jansen G; Cloos J; Peters GJ
    Nucleosides Nucleotides Nucleic Acids; 2020; 39(10-12):1379-1388. PubMed ID: 32312148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FLT3 is implicated in cytarabine transport by human equilibrative nucleoside transporter 1 in pediatric acute leukemia.
    Català A; Pastor-Anglada M; Caviedes-Cárdenas L; Malatesta R; Rives S; Vega-García N; Camós M; Fernández-Calotti P
    Oncotarget; 2016 Aug; 7(31):49786-49799. PubMed ID: 27391351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and hepatobiliary transport characteristics of the concentrative and equilibrative nucleoside transporters in sandwich-cultured human hepatocytes.
    Govindarajan R; Endres CJ; Whittington D; LeCluyse E; Pastor-Anglada M; Tse CM; Unadkat JD
    Am J Physiol Gastrointest Liver Physiol; 2008 Sep; 295(3):G570-80. PubMed ID: 18635603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunocytochemical detection of hENT1 and hCNT1 in normal tissues, lung cancer cell lines, and NSCLC patient samples.
    Hubeek I; Giovannetti E; Broekhuizen AJ; Pastor-Anglada M; Kaspers GJ; Peters GJ
    Nucleosides Nucleotides Nucleic Acids; 2008 Jun; 27(6):787-93. PubMed ID: 18600541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the nucleoside-derived drug transporters hCNT1, hENT1 and hENT2 in gynecologic tumors.
    Farré X; Guillén-Gómez E; Sánchez L; Hardisson D; Plaza Y; Lloberas J; Casado FJ; Palacios J; Pastor-Anglada M
    Int J Cancer; 2004 Dec; 112(6):959-66. PubMed ID: 15386342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous expression of hCNT1-CFP and hENT1-YFP in Madin-Darby canine kidney cells. Localization and vectorial transport studies.
    Lai Y; Bakken AH; Unadkat JD
    J Biol Chem; 2002 Oct; 277(40):37711-7. PubMed ID: 12097333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial expression of the human equilibrative nucleoside transporter 1 (hENT1) results in enhanced mitochondrial toxicity of antiviral drugs.
    Lai Y; Tse CM; Unadkat JD
    J Biol Chem; 2004 Feb; 279(6):4490-7. PubMed ID: 14607828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of human equilibrative nucleoside transporter 1 (hENT1) and its correlation with gemcitabine uptake and cytotoxicity in mantle cell lymphoma.
    Marcé S; Molina-Arcas M; Villamor N; Casado FJ; Campo E; Pastor-Anglada M; Colomer D
    Haematologica; 2006 Jul; 91(7):895-902. PubMed ID: 16818276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of human equilibrative nucleoside transporter 1 on the cellular transport of the DNA methyltransferase inhibitors 5-azacytidine and CP-4200 in human leukemia cells.
    Hummel-Eisenbeiss J; Hascher A; Hals PA; Sandvold ML; Müller-Tidow C; Lyko F; Rius M
    Mol Pharmacol; 2013 Sep; 84(3):438-50. PubMed ID: 23814180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular requirements of the human nucleoside transporters hCNT1, hCNT2, and hENT1.
    Chang C; Swaan PW; Ngo LY; Lum PY; Patil SD; Unadkat JD
    Mol Pharmacol; 2004 Mar; 65(3):558-70. PubMed ID: 14978234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The differential expression of hCNT1 and hENT1 i n breast cancer and the possible impact on breast cancer therapy.
    Lane J; Martin TA; McGuigan C; Mason MD; Jiang WG
    J Exp Ther Oncol; 2010; 8(3):203-10. PubMed ID: 20734919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential mRNA expression of Ara-C-metabolizing enzymes explains Ara-C sensitivity in MLL gene-rearranged infant acute lymphoblastic leukemia.
    Stam RW; den Boer ML; Meijerink JP; Ebus ME; Peters GJ; Noordhuis P; Janka-Schaub GE; Armstrong SA; Korsmeyer SJ; Pieters R
    Blood; 2003 Feb; 101(4):1270-6. PubMed ID: 12406912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II study of elacytarabine in combination with idarubicin and of human equilibrative nucleoside transporter 1 expression in patients with acute myeloid leukemia and persistent blasts after the first induction course.
    Rizzieri D; Vey N; Thomas X; Huguet-Rigal F; Schlenk RF; Krauter J; Kindler T; Gjertsen BT; Blau IW; Jacobsen TF; Johansen M; Bergeland T; Gianella-Borradori A; Krug U
    Leuk Lymphoma; 2014 Sep; 55(9):2114-9. PubMed ID: 24255981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective Inhibition of Human Equilibrative and Concentrative Nucleoside Transporters by BCR-ABL Kinase Inhibitors: IDENTIFICATION OF KEY hENT1 AMINO ACID RESIDUES FOR INTERACTION WITH BCR-ABL KINASE INHIBITORS.
    Damaraju VL; Weber D; Kuzma M; Cass CE; Sawyer MB
    J Biol Chem; 2016 Sep; 291(36):18809-17. PubMed ID: 27432881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The MUC4 mucin mediates gemcitabine resistance of human pancreatic cancer cells via the Concentrative Nucleoside Transporter family.
    Skrypek N; Duchêne B; Hebbar M; Leteurtre E; van Seuningen I; Jonckheere N
    Oncogene; 2013 Mar; 32(13):1714-23. PubMed ID: 22580602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of fused-pyrimidine nucleoside analogs with human concentrative nucleoside transporters: High-affinity inhibitors of human concentrative nucleoside transporter 1.
    Damaraju VL; Smith KM; Mowles D; Nowak I; Karpinski E; Young JD; Robins MJ; Cass CE
    Biochem Pharmacol; 2011 Jan; 81(1):82-90. PubMed ID: 20854794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression Levels of Human Equilibrative Nucleoside Transporter 1 and Deoxycytidine Kinase Enzyme as Prognostic Factors in Patients with Acute Myeloid Leukemia Treated with Cytarabine.
    Candelaria M; Corrales-Alfaro C; Gutiérrez-Hernández O; Díaz-Chavez J; Labardini-Méndez J; Vidal-Millán S; Herrera LA
    Chemotherapy; 2016; 61(6):313-8. PubMed ID: 27119162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of broadly selective equilibrative and concentrative nucleoside transporters, hENT1 and hCNT3, in human kidney.
    Damaraju VL; Elwi AN; Hunter C; Carpenter P; Santos C; Barron GM; Sun X; Baldwin SA; Young JD; Mackey JR; Sawyer MB; Cass CE
    Am J Physiol Renal Physiol; 2007 Jul; 293(1):F200-11. PubMed ID: 17409283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleoside transporter profiles in human pancreatic cancer cells: role of hCNT1 in 2',2'-difluorodeoxycytidine- induced cytotoxicity.
    García-Manteiga J; Molina-Arcas M; Casado FJ; Mazo A; Pastor-Anglada M
    Clin Cancer Res; 2003 Oct; 9(13):5000-8. PubMed ID: 14581375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of human nucleoside transporters in the uptake and cytotoxicity of azacitidine and decitabine.
    Damaraju VL; Mowles D; Yao S; Ng A; Young JD; Cass CE; Tong Z
    Nucleosides Nucleotides Nucleic Acids; 2012; 31(3):236-55. PubMed ID: 22356238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.